Published
March 12, 2024
Case Study: Cord Blood Transplants Offer A Lifeline for Leukemia Patients
Medically reviewed by
In early August 2015, Chris Lihosit experienced a puzzling illness characterized by an exhausting fever that vanished after two days. Initially dismissed as summertime flu, the recurring pattern of midweek chills and escalating fevers raised concerns. Chris, a software developer at T-Mobile, couldn't ignore his declining physical condition, especially as he struggled with routine tasks and faced breathlessness even at sea level. A heart murmur and suspicions of endocarditis prompted a series of medical tests, leading Chris and his husband, Bill Sechter, to the Emergency Room 4 at the University of Washington Medical Center.
The revelation came swiftly: Chris's infection-fighting neutrophil cells had plummeted, leaving his immune system compromised. He was also severely anemic, indicating an underlying issue beyond endocarditis. Further tests unveiled acute myeloid leukemia (AML), a fast-progressing cancer, with an alarming 80 percent of his bone marrow cells affected. With chemotherapy looming, Chris underwent sperm banking and shared an emotional Facebook post, bracing for the battle ahead.
Chemotherapy commenced, but complications emerged, including blood clots and bacterial infections. Despite the setbacks, Chris's resilience shone through as he marked each treatment milestone with humor and determination. Eventually, a bone marrow transplant emerged as the best chance for survival, but finding a compatible donor posed a challenge due to Chris's rare genetic markers.
Amidst the uncertainties, hope arrived in the form of cord blood transplants, offering a lifeline for patients like Chris. A rigorous treatment regimen followed, with chemotherapy, radiation therapy, and a cord blood transplant from three newborn donors named Amelia, Olivia, and Eddie. The procedure marked a pivotal moment, heralding the beginning of Chris's journey towards recovery.
In the days that followed, Chris battled exhaustion, infections, and physical limitations, but he remained steadfast in his resolve to overcome adversity. With unwavering support from his family and medical team, Chris emerged victorious, celebrating his "zero birthday" as his body received a new lease on life.
Cord blood transplants, once a last resort, have emerged as a promising treatment option for leukemia patients, offering hope and healing where none seemed possible. As researchers continue to explore innovative strategies to improve transplant outcomes, patients like Chris serve as beacons of resilience and courage, inspiring others to never lose hope in the face of adversity.
Keep on reading
